Literature DB >> 28401179

Role of SEC62 in ER maintenance: A link with ER stress tolerance in SEC62-overexpressing tumors?

Timothy J Bergmann1, Fiorenza Fumagalli2, Marisa Loi1, Maurizio Molinari3.   

Abstract

Amplification of the candidate oncogene TLOC1/SEC62 in tumors correlates with reduced patient survival. The recently reported role of SEC62 as an autophagy receptor that controls endoplasmic reticulum (ER) size and function might open new scenarios for understanding the phenotypes and treat SEC62high tumors, which are characterized by high ER stress tolerance.

Entities:  

Keywords:  Autophagy receptor; ER-phagy; LIR; SEC62; TLOC1; cancer; endoplasmic reticulum; oncogene; recovER-phagy; selective autophagy; tumor

Year:  2017        PMID： 28401179      PMCID： PMC5383369          DOI： 10.1080/23723556.2016.1264351

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN： 2372-3556


  9 in total

Review 1.  The unfolded protein response: from stress pathway to homeostatic regulation.

Authors:  Peter Walter; David Ron
Journal:  Science       Date:  2011-11-25       Impact factor: 47.728

2.  Protein transport into the endoplasmic reticulum: mechanisms and pathologies.

Authors:  Richard Zimmermann; Linda Müller; Bernd Wullich
Journal:  Trends Mol Med       Date:  2006-10-30       Impact factor: 11.951

3.  Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery.

Authors:  Fiorenza Fumagalli; Julia Noack; Timothy J Bergmann; Eduardo Cebollero; Giorgia Brambilla Pisoni; Elisa Fasana; Ilaria Fregno; Carmela Galli; Marisa Loi; Tatiana Soldà; Rocco D'Antuono; Andrea Raimondi; Martin Jung; Armin Melnyk; Stefan Schorr; Anne Schreiber; Luca Simonelli; Luca Varani; Caroline Wilson-Zbinden; Oliver Zerbe; Kay Hofmann; Matthias Peter; Manfredo Quadroni; Richard Zimmermann; Maurizio Molinari
Journal:  Nat Cell Biol       Date:  2016-10-17       Impact factor: 28.824

4.  Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer.

Authors:  Maximilian Linxweiler; Johannes Linxweiler; Monika Barth; Julia Benedix; Volker Jung; Yoo-Jin Kim; Rainer M Bohle; Richard Zimmermann; Markus Greiner
Journal:  Am J Pathol       Date:  2011-12-21       Impact factor: 4.307

5.  Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.

Authors:  Markus Greiner; Birgit Kreutzer; Volker Jung; Rainer Grobholz; Andrea Hasenfus; Robert Franz Stöhr; Luigi Tornillo; Johanna Dudek; Michael Stöckle; Gerhard Unteregger; Jörn Kamradt; Bernd Wullich; Richard Zimmermann
Journal:  Int J Cancer       Date:  2011-05-15       Impact factor: 7.396

6.  Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers.

Authors:  Daniel Hagerstrand; Alexander Tong; Steven E Schumacher; Nina Ilic; Rhine R Shen; Hiu Wing Cheung; Francisca Vazquez; Yashaswi Shrestha; So Young Kim; Andrew O Giacomelli; Joseph Rosenbluh; Anna C Schinzel; Nicole A Spardy; David A Barbie; Craig H Mermel; Barbara A Weir; Levi A Garraway; Pablo Tamayo; Jill P Mesirov; Rameen Beroukhim; William C Hahn
Journal:  Cancer Discov       Date:  2013-06-13       Impact factor: 39.397

7.  Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection.

Authors:  Li Weng; Juan Du; Qinghui Zhou; Binbin Cheng; Jun Li; Denghai Zhang; Changquan Ling
Journal:  Mol Cancer       Date:  2012-06-08       Impact factor: 27.401

8.  A morphometric study of the removal of phenobarbital-induced membranes from hepatocytes after cessation of threatment.

Authors:  R P Bolender; E R Weibel
Journal:  J Cell Biol       Date:  1973-03       Impact factor: 10.539

9.  Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: a clinically tested small molecule phenocopy of SEC62 gene silencing in human tumor cells.

Authors:  Maximilian Linxweiler; Stefan Schorr; Nico Schäuble; Martin Jung; Johannes Linxweiler; Frank Langer; Hans-Joachim Schäfers; Adolfo Cavalié; Richard Zimmermann; Markus Greiner
Journal:  BMC Cancer       Date:  2013-12-05       Impact factor: 4.430
  9 in total
  17 in total

1.  Endoplasmic Reticulum (ER) and ER-Phagy.

Authors:  Marisa Loi; Alessandro Marazza; Maurizio Molinari
Journal:  Prog Mol Subcell Biol       Date:  2021

Review 2.  ER-phagy and human diseases.

Authors:  Christian A Hübner; Ivan Dikic
Journal:  Cell Death Differ       Date:  2019-10-28       Impact factor: 15.828

Review 3.  ER-phagy: mechanisms, regulation, and diseases connected to the lysosomal clearance of the endoplasmic reticulum.

Authors:  Fulvio Reggiori; Maurizio Molinari
Journal:  Physiol Rev       Date:  2022-02-21       Impact factor: 46.500

Review 4.  Complexity and Specificity of Sec61-Channelopathies: Human Diseases Affecting Gating of the Sec61 Complex.

Authors:  Mark Sicking; Sven Lang; Florian Bochen; Andreas Roos; Joost P H Drenth; Muhammad Zakaria; Richard Zimmermann; Maximilian Linxweiler
Journal:  Cells       Date:  2021-04-27       Impact factor: 6.600

5.  Deep learning approach for quantification of organelles and misfolded polypeptide delivery within degradative compartments.

Authors:  Diego Morone; Alessandro Marazza; Timothy J Bergmann; Maurizio Molinari
Journal:  Mol Biol Cell       Date:  2020-05-13       Impact factor: 4.138

Review 6.  Eat it right: ER-phagy and recovER-phagy.

Authors:  Marisa Loi; Ilaria Fregno; Concetta Guerra; Maurizio Molinari
Journal:  Biochem Soc Trans       Date:  2018-05-25       Impact factor: 5.407

Review 7.  ER-phagy: shaping up and destressing the endoplasmic reticulum.

Authors:  Simon Wilkinson
Journal:  FEBS J       Date:  2019-06-10       Impact factor: 5.542

8.  ESCRT-III-driven piecemeal micro-ER-phagy remodels the ER during recovery from ER stress.

Authors:  Marisa Loi; Andrea Raimondi; Diego Morone; Maurizio Molinari
Journal:  Nat Commun       Date:  2019-11-07       Impact factor: 14.919

9.  Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology.

Authors:  Molly Went; Amit Sud; Helen Speedy; Nicola J Sunter; Asta Försti; Philip J Law; David C Johnson; Fabio Mirabella; Amy Holroyd; Ni Li; Giulia Orlando; Niels Weinhold; Mark van Duin; Bowang Chen; Jonathan S Mitchell; Larry Mansouri; Gunnar Juliusson; Karin E Smedby; Sandrine Jayne; Aneela Majid; Claire Dearden; David J Allsup; James R Bailey; Guy Pratt; Chris Pepper; Chris Fegan; Richard Rosenquist; Rowan Kuiper; Owen W Stephens; Uta Bertsch; Peter Broderick; Hermann Einsele; Walter M Gregory; Jens Hillengass; Per Hoffmann; Graham H Jackson; Karl-Heinz Jöckel; Jolanta Nickel; Markus M Nöthen; Miguel Inacio da Silva Filho; Hauke Thomsen; Brian A Walker; Annemiek Broyl; Faith E Davies; Markus Hansson; Hartmut Goldschmidt; Martin J S Dyer; Martin Kaiser; Pieter Sonneveld; Gareth J Morgan; Kari Hemminki; Björn Nilsson; Daniel Catovsky; James M Allan; Richard S Houlston
Journal:  Blood Cancer J       Date:  2018-12-21       Impact factor: 11.037

Review 10.  Reticulon Homology Domain-Containing Proteins and ER-Phagy.

Authors:  Manuela D'Eletto; Serafina Oliverio; Federica Di Sano
Journal:  Front Cell Dev Biol       Date:  2020-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.